APA Alıntı

Sakai, K., Someya, T., Harada, K., Yagi, H., Matsui, T., & Matsumoto, M. (2019). Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab. Haematologica.

Chicago Stili Alıntı

Sakai, Kazuya, Tatsuhiko Someya, Kaori Harada, Hideo Yagi, Taei Matsui, ve Masanori Matsumoto. "Novel Aptamer to Von Willebrand Factor A1 Domain (TAGX-0004) Shows Total Inhibition of Thrombus Formation Superior to ARC1779 and Comparable to Caplacizumab." Haematologica 2019.

MLA Alıntı

Sakai, Kazuya, et al. "Novel Aptamer to Von Willebrand Factor A1 Domain (TAGX-0004) Shows Total Inhibition of Thrombus Formation Superior to ARC1779 and Comparable to Caplacizumab." Haematologica 2019.